treatments
OBJECTIVE: We evaluated liver disease in conventionally treated type 2 diabetic       patients to provide a reference against which reports of liver disease related to       novel oral antidiabetic treatments could be compared.
OBJECTIVE: We evaluated liver disease in conventionally treated type 2 diabetic       patients to provide a reference against which reports of liver disease related to       novel oral  @OBJECT$  @PREDICAT$  @SUBJECT$  could be compared.